1. Identification of a small chemical as a lysosomal calcium mobilizer and characterization of its ability to inhibit autophagy and viral infection. Zhang Kehui, Huang Lihong, Cai Yang, Zhong Yi, Chen Nanjun, Gao Fei, Zhang Liang, Li Qi, Liu Zhenming, Zhang Rongxin, Zhang Liangren, Yue Jianbo*. FEBS J. 2023.
2. Bioevaluation of a dual PI3K/HDAC inhibitor for the treatment of diffuse large B-cell lymphoma. Zhang Kehui, Huang Lei, Lai Fangfang, Lin Songwen, Tian Hua, Wu Deyu, Chen Xiaoguang*, Xu Heng*. Bioorganic & Medicinal Chemistry Letters, 2022, 71, 128825.
3. Design, synthesis, and biological evaluation of a novel photocaged PI3K inhibitor toward precise cancer treatment. Zhang Kehui, Ji Ming, Lin Songwen, Peng Shouguo, Zhang Zhihui, Zhang Mingyi, Zhang Jingbo, Zhang Yan, Wu Deyu, Tian Hua, Chen Xiaoguang*, Xu Heng*. Journal of Medicinal Chemistry, 2021, 64, 7331-7340.(补充封面论文)
4. Design, synthesis, and biological evaluation of 4-methyl quinazoline derivatives as anticancer agents simultaneously targeting phosphoinositide 3-kinases and histone deacetylases. Zhang Kehui, Lai Fangfang, Lin Songwen, Ji Ming, Zhang Jingbo, Zhang Yan, Jin Jing, Fu Rong, Wu Deyu, Tian Hua, Xue Nina, Sheng Li, Zou Xiaowen, Li Yan, Chen Xiaoguang*, Xu Heng*. Journal of Medicinal Chemistry, 2019, 62, 6992-7014.(封面论文)
5. Identifying glyceraldehyde 3-phosphate dehydrogenase as a cyclic adenosine diphosphoribose binding protein by photoaffinity protein–ligand labeling approach. Zhang Kehui, Sun Wei, Huang Lihong, Zhu Kaiyuan, Pei Fen, Zhu Longchao, Wang Qian, Lu Yingying, Zhang Hongmin, Jin Hongwei, Zhang Li-He*, Zhang Liangren*, Yue Jianbo*. Journal of the American Chemical Society, 2017, 139, 156-170.